240 related articles for article (PubMed ID: 21421114)
1. Molecular heterogeneity in glioblastoma: therapeutic opportunities and challenges.
Nicholas MK; Lukas RV; Chmura S; Yamini B; Lesniak M; Pytel P
Semin Oncol; 2011 Apr; 38(2):243-53. PubMed ID: 21421114
[TBL] [Abstract][Full Text] [Related]
2. Molecular advances of brain tumors in radiation oncology.
Noda SE; El-Jawahri A; Patel D; Lautenschlaeger T; Siedow M; Chakravarti A
Semin Radiat Oncol; 2009 Jul; 19(3):171-8. PubMed ID: 19464632
[TBL] [Abstract][Full Text] [Related]
3. Understanding glioblastoma tumor biology: the potential to improve current diagnosis and treatments.
Kesari S
Semin Oncol; 2011 Dec; 38 Suppl 4():S2-10. PubMed ID: 22078644
[TBL] [Abstract][Full Text] [Related]
4. Recurrent glioblastoma: a fresh look at current therapies and emerging novel approaches.
Gilbert MR
Semin Oncol; 2011 Dec; 38 Suppl 4():S21-33. PubMed ID: 22078645
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic strategies for inhibiting invasion in glioblastoma.
Drappatz J; Norden AD; Wen PY
Expert Rev Neurother; 2009 Apr; 9(4):519-34. PubMed ID: 19344303
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic advances in the treatment of glioblastoma: rationale and potential role of targeted agents.
Reardon DA; Wen PY
Oncologist; 2006 Feb; 11(2):152-64. PubMed ID: 16476836
[TBL] [Abstract][Full Text] [Related]
7. [Progress in the study of brain tumor stem cells as treatment targets].
Hide T; Kuratsu J
Brain Nerve; 2009 Jul; 61(7):781-9. PubMed ID: 19618855
[TBL] [Abstract][Full Text] [Related]
8. The EGFRvIII variant in glioblastoma multiforme.
Gan HK; Kaye AH; Luwor RB
J Clin Neurosci; 2009 Jun; 16(6):748-54. PubMed ID: 19324552
[TBL] [Abstract][Full Text] [Related]
9. Glioblastoma therapy: going beyond Hercules Columns.
Mangiola A; Anile C; Pompucci A; Capone G; Rigante L; De Bonis P
Expert Rev Neurother; 2010 Apr; 10(4):507-14. PubMed ID: 20367204
[TBL] [Abstract][Full Text] [Related]
10. Molecular predictors in glioblastoma: toward personalized therapy.
Colman H; Aldape K
Arch Neurol; 2008 Jul; 65(7):877-83. PubMed ID: 18625854
[TBL] [Abstract][Full Text] [Related]
11. Chromogenic in situ hybridization accurately identifies EGFR amplification in small cell glioblastoma multiforme, a common subtype of primary GBM.
Quezado M; Ronchetti R; Rapkiewicz A; Santi M; Blumenthal DT; Rushing EJ
Clin Neuropathol; 2005; 24(4):163-9. PubMed ID: 16033132
[TBL] [Abstract][Full Text] [Related]
12. EGF receptor inhibitors in the treatment of glioblastoma multiform: old clinical allies and newly emerging therapeutic concepts.
Gadji M; Crous AM; Fortin D; Krcek J; Torchia M; Mai S; Drouin R; Klonisch T
Eur J Pharmacol; 2009 Dec; 625(1-3):23-30. PubMed ID: 19836372
[TBL] [Abstract][Full Text] [Related]
13. Glioblastoma multiforme: a review of where we have been and where we are going.
Adamson C; Kanu OO; Mehta AI; Di C; Lin N; Mattox AK; Bigner DD
Expert Opin Investig Drugs; 2009 Aug; 18(8):1061-83. PubMed ID: 19555299
[TBL] [Abstract][Full Text] [Related]
14. Gene therapeutics: the future of brain tumor therapy?
Cutter JL; Kurozumi K; Chiocca EA; Kaur B
Expert Rev Anticancer Ther; 2006 Jul; 6(7):1053-64. PubMed ID: 16831077
[TBL] [Abstract][Full Text] [Related]
15. The infrequent simultaneous genetic alterations in glioblastoma multiforme (LOH 10, 17, 19q, TP53 mutation and EGFR amplification) with short clinical course.
Jesionek-Kupnicka D; Kulczycka D; Rieske P; Szybka M; Jabłońska J; Potemski P; Kolasa P; Liberski PP; Kordek R
Pol J Pathol; 2007; 58(2):79-85. PubMed ID: 17715673
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme.
Quan AL; Barnett GH; Lee SY; Vogelbaum MA; Toms SA; Staugaitis SM; Prayson RA; Peereboom DM; Stevens GH; Cohen BH; Suh JH
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):695-703. PubMed ID: 15936158
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas.
Nicholas MK; Lukas RV; Jafri NF; Faoro L; Salgia R
Clin Cancer Res; 2006 Dec; 12(24):7261-70. PubMed ID: 17189397
[TBL] [Abstract][Full Text] [Related]
18. EGFR targeted inhibition resistance: compensatory activation of ERBB family members in glioblastoma cancer stem-like cells promotes proliferation.
Gursel DB; Schlaff CD; Boockvar JA
Neurosurgery; 2012 Oct; 71(4):N17-8. PubMed ID: 22989968
[No Abstract] [Full Text] [Related]
19. Glioblastoma multiforme: Pathogenesis and treatment.
Alifieris C; Trafalis DT
Pharmacol Ther; 2015 Aug; 152():63-82. PubMed ID: 25944528
[TBL] [Abstract][Full Text] [Related]
20. High-grade astrocytomas.
Wen PY; Fine HA; Black PM; Shrieve DC; Alexander E; Loeffler JS
Neurol Clin; 1995 Nov; 13(4):875-900. PubMed ID: 8584002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]